
An allegation of plagiarism in a paper about Covid-19 in people with diabetes led to a retraction, but not for lifted text.
Earlier this year, the journal Diabetes Technology & Therapeutics, a Mary Ann Liebert title, published “No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes.” The author was Pilar Isabel Beato-Vi[accent over i]bora, of University Hospital Complex Badajoz, in Spain.
According to the article, the lockdown of Spain in response to the pandemic did not seem to make it harder for people with type 1 diabetes there to control their blood sugar.
The finding made at least one headline, in Medscape, which covered the paper when it appeared online in May.
But it also sounded alarms with at least one reader. As the retraction notice explains:
Continue reading Diabetes-COVID-19 paper retracted for lack of ethical approval